Emma Kempe
University of Sydney, NEW SOUTH WALES, Australia
- This delegate is presenting an abstract at this event.
I am a PhD Candidate at the University of Sydney studying drug-tolerant persister cells in glioblastoma.
Presentations this author is a contributor to:
Histone methyltransferase PRDM9 promotes survival of drug-tolerant persister cells in glioblastoma (#172)
5:40 PM
Emma G Kempe
Welcome Reception & Poster Session 1
PRDM9-Mediated H3K4me3 Drives Cholesterol Metabolic Gene Expression and Chemotherapy Tolerance in Glioblastoma (#168)
5:40 PM
George L Joun
Welcome Reception & Poster Session 1
CANCER 2026